查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1613310

去矿骨基质市场：按产品、剂型、应用和最终用途 - 2025-2030 年全球预测

Demineralized Bone Matrix Market by Product (Gel, Putty, Putty Combined with Cancellous Chips), Administration Mode (Implantation, Injection), Application, End-Use - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年脱矿骨基质市场价值为6.7114亿美元，预计到2024年将达到7.1336亿美元，复合年增长率为6.54%，预计到2030年将达到10.4637亿美元。

脱矿骨基质（DBM）是整形外科和重组手术必需的生物材料，由透过同种异体骨脱矿获得的胶原蛋白、骨蛋白和生长因子组成。 DBM的主要应用是促进骨诱导、促进骨再生，对于脊椎融合手术、创伤修復、骨缺损等至关重要。 DBM 的应用非常广泛，包括脊椎手术、牙科手术和关节重组，最终用途包括医院、专科诊所和研究机构。影响 DBM 市场的主要成长要素包括整形外科疾病盛行率的上升、老年人口的增加、再生医学的进步以及对新手术技术认识的提高。此外，对微创手术的需求正在推动市场扩张。潜在的机会可能在于扩大产品线、将 DBM 与 3D 列印等先进技术相结合，以及进入医疗保健基础设施快速发展的新兴市场。然而，DBM产品的高价格、严格的法律规范以及同种异体移植疾病传播的风险等挑战也可能阻碍成长。此外，来自合成骨移植替代品的竞争也增加了额外的压力。创新领域包括开发具有更高骨诱导性的 DBM、探索与生物活性材料的组合以提高功效，以及优化製造流程以提高成本效率。该市场的特点是竞争重点放在产品差异化和技术进步的研发、合作和伙伴关係关係。为了业务成长，建议建立强大的销售网络并在研究方面形成策略联盟，以开发下一代 DBM 产品。持续监控监管变化和报销趋势对于驾驭这个充满活力的市场也至关重要。

主要市场统计
基准年[2023] 67114万美元
预计年份 [2024] 71336万美元
预测年份 [2030] 10.4637 亿美元
复合年增长率（%） 6.54%

市场动态：快速发展的脱矿骨基质市场的关键市场洞察

供需的动态交互作用正在改变去矿骨基质市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助消费行为及其对製造业的影响。

  • 市场驱动因素
    • 骨损伤的增加和整形外科手术的普及
    • 政府投资促进整形外科研究活动
  • 市场限制因素
    • 去矿骨基质的高成本和报销限制
  • 市场机会
    • 脱矿骨基质材料的研究进展
    • 相关人员之间的合作以供应脱矿质骨基质
  • 市场挑战
    • 对脱矿骨基质的品质和一致性的担忧

波特五力：驾驭脱矿骨基质市场的策略工具

波特的五力框架是了解脱矿骨基质市场竞争格局的关键工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解脱矿骨基质市场的外部影响

外部宏观环境因素在塑造脱矿骨基质市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解脱矿骨基质市场的竞争格局

对脱矿骨基质市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵去矿骨矩阵市场供应商的绩效评估

FPNV定位矩阵是评估去矿骨基质市场供应商的关键工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议，以规划去矿骨基质市场的成功之路

对于旨在加强在全球市场的影响力的公司来说，脱矿骨基质市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5.产品开发与创新：重点关注可望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 骨损伤的增加和整形外科手术的引入
      • 政府投资促进整形外科研究活动
    • 抑制因素
      • 去矿骨基质的高成本和报销限制
    • 机会
      • 脱矿骨基质材料的研究进展
      • 相关人员之间在脱矿骨基质供应方面的合作
    • 任务
      • 对脱矿骨基质的品质和一致性的担忧
  • 市场区隔分析
    • 产品：在各种骨骼修復情况下采用腻子与 DBM 的鬆质骨碎片结合
    • 应用：DBM在整形外科手术的快速实施
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章脱矿骨基质市场：副产品

  • 凝胶
  • 油灰
  • 腻子和海绵碎片的组合

第七章依管理模式分類的脱钙骨基质市场

  • 移植
  • 注射

第八章脱矿骨基质市场：依应用分类

  • 颅颚颜面外科
  • 牙齿重组
  • 关节重组
  • 整形外科修復
  • 脊椎融合手术

第九章脱矿骨基质市场：依最终用途分类

  • 医院
  • 专科诊所

第十章美洲脱矿骨基质市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太地区去矿骨基质市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲脱钙骨基质市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Paragon 28 推出 BEAST 皮质纤维，扩大生技药品产品组合
    • Biogenics 推出 Osteospan 纤维基质
    • Geistlich 宣布大幅扩展同种异体移植产品组合
  • 战略分析和建议

公司名单

  • Advanced Biotech Products P Ltd
  • AlloSource
  • Arthrex, Inc.
  • Bioventus LLC
  • Cerapedics.Inc.
  • Curasan AG
  • Exactech, Inc.
  • Geistlich Pharma AG
  • Globus Medical
  • HansBioMed.
  • Institut Straumann AG
  • Integra LifeSciences Holdings Corporation
  • Johnson & Johnson Services, Inc.
  • KLS Martin SE & Co. KG
  • Kuros Biosciences Ltd.
  • Medtronic PLC
  • NovaBone by Halma PLC
  • Orthofix Medical Inc.
  • Osteogenics Biomedical
  • RTI Surgical Holdings, Inc.
  • SpineWave, Inc.
  • Stryker Corporation
  • Synerheal
  • XTANT Medical
  • Zimmer Biomet
Product Code: MRR-F97DD5A7D66F

The Demineralized Bone Matrix Market was valued at USD 671.14 million in 2023, expected to reach USD 713.36 million in 2024, and is projected to grow at a CAGR of 6.54%, to USD 1,046.37 million by 2030.

Demineralized Bone Matrix (DBM) is a vital biomaterial in orthopedic and reconstructive surgery, composed of collagen, bone proteins, and growth factors derived through the decalcification of allograft bone. Its primary necessity lies in promoting osteoinduction and enhancing bone regeneration, essential in spinal fusions, trauma repair, and bone defects. DBM's application is vast, utilized in spine surgery, dental surgeries, and joint reconstruction, with its end-use scope spanning hospitals, specialty clinics, and research institutes. Key growth factors influencing the DBM market include the rising prevalence of orthopedic disorders, increasing geriatric population, advancements in regenerative medicine, and growing awareness of novel surgical techniques. Moreover, the demand for minimally invasive surgeries fosters market expansion. Potential opportunities can be found in the expansion of product lines, integration of DBM with advanced technologies like 3D printing, and entering emerging markets where healthcare infrastructure is evolving rapidly. However, challenges exist, such as the high cost of DBM products, stringent regulatory frameworks, and risks of disease transmission from allograft sources, which may hinder growth. Furthermore, the competition from synthetic bone graft substitutes adds additional pressure. Innovation areas include the development of DBM with enhanced osteoinductive properties, exploring its combination with bioactive materials for greater efficacy, and optimizing manufacturing processes for cost efficiency. The market is characterized by its competitive nature with a focus on R&D, collaborations, and partnerships aimed at product differentiation and technological advancements. For business growth, strategic partnerships in research for developing next-generation DBM products, alongside establishing a robust distribution network, are recommended. Continual monitoring of regulatory changes and reimbursement trends is also critical to navigating this dynamic market.

KEY MARKET STATISTICS
Base Year [2023] USD 671.14 million
Estimated Year [2024] USD 713.36 million
Forecast Year [2030] USD 1,046.37 million
CAGR (%) 6.54%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Demineralized Bone Matrix Market

The Demineralized Bone Matrix Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence of bone injuries and adoption of orthopedic surgeries
    • Government investments promoting orthopedic research activities
  • Market Restraints
    • High cost and reimbursement limitations of demineralized bone matrix
  • Market Opportunities
    • Advancements in the demineralized bone matrix materials
    • Collaboration between stakeholders for supply of demineralized bone matrix
  • Market Challenges
    • Quality and consistency concerns of demineralized bone matrix

Porter's Five Forces: A Strategic Tool for Navigating the Demineralized Bone Matrix Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Demineralized Bone Matrix Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Demineralized Bone Matrix Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Demineralized Bone Matrix Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Demineralized Bone Matrix Market

A detailed market share analysis in the Demineralized Bone Matrix Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Demineralized Bone Matrix Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Demineralized Bone Matrix Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Demineralized Bone Matrix Market

A strategic analysis of the Demineralized Bone Matrix Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Demineralized Bone Matrix Market, highlighting leading vendors and their innovative profiles. These include Advanced Biotech Products P Ltd, AlloSource, Arthrex, Inc., Bioventus LLC, Cerapedics.Inc., Curasan AG, Exactech, Inc., Geistlich Pharma AG, Globus Medical, HansBioMed., Institut Straumann AG, Integra LifeSciences Holdings Corporation, Johnson & Johnson Services, Inc., KLS Martin SE & Co. KG, Kuros Biosciences Ltd., Medtronic PLC, NovaBone by Halma PLC, Orthofix Medical Inc., Osteogenics Biomedical, RTI Surgical Holdings, Inc., SpineWave, Inc., Stryker Corporation, Synerheal, XTANT Medical, and Zimmer Biomet.

Market Segmentation & Coverage

This research report categorizes the Demineralized Bone Matrix Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Gel, Putty, and Putty Combined with Cancellous Chips.
  • Based on Administration Mode, market is studied across Implantation and Injection.
  • Based on Application, market is studied across Craniomaxillofacial Surgeries, Dental Reconstructions, Joint Reconstruction, Orthopedic Repairs, and Spinal Fusion Surgery.
  • Based on End-Use, market is studied across Hospitals and Specialty Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of bone injuries and adoption of orthopedic surgeries
      • 5.1.1.2. Government investments promoting orthopedic research activities
    • 5.1.2. Restraints
      • 5.1.2.1. High cost and reimbursement limitations of demineralized bone matrix
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements in the demineralized bone matrix materials
      • 5.1.3.2. Collaboration between stakeholders for supply of demineralized bone matrix
    • 5.1.4. Challenges
      • 5.1.4.1. Quality and consistency concerns of demineralized bone matrix
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Adoption of putty combined with cancellous chips form of DBM for extensive bone repair situations
    • 5.2.2. Application: Exponential adoption of DBM for orthopedic surgical procedures
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Demineralized Bone Matrix Market, by Product

  • 6.1. Introduction
  • 6.2. Gel
  • 6.3. Putty
  • 6.4. Putty Combined with Cancellous Chips

7. Demineralized Bone Matrix Market, by Administration Mode

  • 7.1. Introduction
  • 7.2. Implantation
  • 7.3. Injection

8. Demineralized Bone Matrix Market, by Application

  • 8.1. Introduction
  • 8.2. Craniomaxillofacial Surgeries
  • 8.3. Dental Reconstructions
  • 8.4. Joint Reconstruction
  • 8.5. Orthopedic Repairs
  • 8.6. Spinal Fusion Surgery

9. Demineralized Bone Matrix Market, by End-Use

  • 9.1. Introduction
  • 9.2. Hospitals
  • 9.3. Specialty Clinics

10. Americas Demineralized Bone Matrix Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Demineralized Bone Matrix Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Demineralized Bone Matrix Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Paragon 28 Launches BEAST Cortical Fibers Expanding its Biologics Portfolio
    • 13.3.2. Biogennix Launches OsteoSPAN Fiber Matrix
    • 13.3.3. Geistlich Announces The Dramatic Expansion Of Their Allograft Portfolio
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Advanced Biotech Products P Ltd
  • 2. AlloSource
  • 3. Arthrex, Inc.
  • 4. Bioventus LLC
  • 5. Cerapedics.Inc.
  • 6. Curasan AG
  • 7. Exactech, Inc.
  • 8. Geistlich Pharma AG
  • 9. Globus Medical
  • 10. HansBioMed.
  • 11. Institut Straumann AG
  • 12. Integra LifeSciences Holdings Corporation
  • 13. Johnson & Johnson Services, Inc.
  • 14. KLS Martin SE & Co. KG
  • 15. Kuros Biosciences Ltd.
  • 16. Medtronic PLC
  • 17. NovaBone by Halma PLC
  • 18. Orthofix Medical Inc.
  • 19. Osteogenics Biomedical
  • 20. RTI Surgical Holdings, Inc.
  • 21. SpineWave, Inc.
  • 22. Stryker Corporation
  • 23. Synerheal
  • 24. XTANT Medical
  • 25. Zimmer Biomet

LIST OF FIGURES

  • FIGURE 1. DEMINERALIZED BONE MATRIX MARKET RESEARCH PROCESS
  • FIGURE 2. DEMINERALIZED BONE MATRIX MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS DEMINERALIZED BONE MATRIX MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS DEMINERALIZED BONE MATRIX MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES DEMINERALIZED BONE MATRIX MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES DEMINERALIZED BONE MATRIX MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC DEMINERALIZED BONE MATRIX MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC DEMINERALIZED BONE MATRIX MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA DEMINERALIZED BONE MATRIX MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA DEMINERALIZED BONE MATRIX MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. DEMINERALIZED BONE MATRIX MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. DEMINERALIZED BONE MATRIX MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. DEMINERALIZED BONE MATRIX MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. DEMINERALIZED BONE MATRIX MARKET DYNAMICS
  • TABLE 7. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY GEL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY PUTTY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY PUTTY COMBINED WITH CANCELLOUS CHIPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY IMPLANTATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY INJECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY CRANIOMAXILLOFACIAL SURGERIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY DENTAL RECONSTRUCTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY JOINT RECONSTRUCTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY ORTHOPEDIC REPAIRS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY SPINAL FUSION SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS DEMINERALIZED BONE MATRIX MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES DEMINERALIZED BONE MATRIX MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC DEMINERALIZED BONE MATRIX MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA DEMINERALIZED BONE MATRIX MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 191. DEMINERALIZED BONE MATRIX MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 192. DEMINERALIZED BONE MATRIX MARKET, FPNV POSITIONING MATRIX, 2023